Connected-Pathology
  • Our Team
    • Careers
  • Services
    • Tx-Connect
    • Preclinical Pathology Services
    • Clinical Pathology Services
    • Digital Pathology
  • News
    • Pathology Blog and Articles
    • Testimonials
  • Contact
Select Page
Digital histopathology company launches integrated platform capable of accelerating drug development

Digital histopathology company launches integrated platform capable of accelerating drug development

Apr 22, 2022 | digital pathology, news, services

New Tx-Connect platform connects researchers with a cutting-edge digital pathology workflow for outsourced histopathology projects  Diepenbeek, Belgium: Connected-Pathology announces the launch of Tx-Connect, a first and critical step towards a fully integrated...

Recent Posts

  • How to Optimally Incorporate Histopathology Readouts to Evaluate the Efficacy of Your Novel Anti-Cancer Compounds 
  • Histopathology Assay Development for Preclinical Research: 10 Key considerations for Antibody Selection  
  • Connected-Pathology increases capacity and speed of processing with suite of newly acquired ROCHE equipment
  • Connected-Pathology selects Agilent software and equipment to support powerful high throughput services
  • Connected-Pathology invests in novel Milestone automation processing instruments, simultaneously becoming Milestone’s prototype testing partner

Recent Comments

  • Histopathology Assay Development for Preclinical Research: 10 Key considerations for Antibody Selection   - Connected-Pathology on Digital histopathology company launches integrated platform capable of accelerating drug development
  • Histopathology Assay Development for Preclinical Research: 10 Key considerations for Antibody Selection   - Connected-Pathology on Connected-Pathology increases capacity and speed of processing with suite of newly acquired ROCHE equipment
  • Histopathology Assay Development for Preclinical Research: 10 Key considerations for Antibody Selection   - Connected-Pathology on Connected-Pathology selects Agilent software and equipment to support powerful high throughput services
  • Histopathology Assay Development for Preclinical Research: 10 Key considerations for Antibody Selection   - Connected-Pathology on Connected-Pathology and KU Leuven Institute for Single Cell OMICS (LISCO) announce a partnership to offer multiplex immunohistochemistry services 
  • Histopathology Assay Development for Preclinical Research: 10 Key considerations for Antibody Selection   - Connected-Pathology on How to assess a service provider when outsourcing histopathology?
Copyright C-Path 2021-2023
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT